Scientists from the University of Leuven in Belgium have found a switch associated with prostate cancers spreading or forming metastases (secondary tumors). The researchers caution that this work is still at an early stage, ...
Jul 17, 2020
0
5
(HealthDay)—African-American (AFR) men with prostate cancer have distinct genomic alterations from European-American (EUR) men, according to a study published online July 10 in Clinical Cancer Research.
Jul 14, 2020
0
1
Researchers have developed a new pair of agents that show exceptional effectiveness for precision diagnosis and treatment of prostate cancer in preclinical studies. The agents, which target prostate-specific membrane antigen ...
Jul 13, 2020
0
2
Prostate cancer is a leading cause of death from cancer in the US and especially in the Philadelphia region. Consistently, Philadelphia has outpaced the state of PA and the nation in diagnoses and death from prostate cancer. ...
Jun 10, 2020
0
7
Over the last decade, enzalutamide and similar drugs have led to significant tumor control and increased survival time for men who have metastatic prostate cancer that continues to grow despite treatments to reduce male hormone ...
Apr 27, 2020
0
70
Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow progression of disease in a subset of men with hormone-sensitive prostate cancers that have spread to a few separate sites ...
Mar 26, 2020
0
41
Scientists at UCL have invented a new test to identify the earliest genetic changes of prostate cancer in blood: a process which could allow doctors to see if cancers have spread, monitor tumour behaviour and enable better ...
Mar 9, 2020
0
149
In a new Cleveland Clinic-led study published in JAMA Oncology, researchers show that a testosterone-related genetic variant—HSD3B1(1245C) - is associated with more aggressive disease and shorter survival in men with metastatic ...
Feb 13, 2020
0
15
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with ...
Sep 30, 2019
0
15
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. ...
Sep 26, 2019
0
3
